Wednesday, January 22, 2014 10:36:21 PM
------------------------------------------------------------------
------------------------------------------------------------------
V 012214 Software Validation Engineer - New! ... job description posted at the bottom, time to verify, lock down and secure.... maybe require some RFID chips for all employees entering Bavi production/storage areas, hey... Bavituximab is pure gold and a life safer... literally!
------------------------------------------------------------------
------------------------------------------------------------------
V 012214 Software Validation Engineer - New!
http://www.avidbio.com/about-us/careers.html
------------------------------------------------------------------
------------------------------------------------------------------
3/25 filled: QA Document Coordinator - AVD 1010
3/21 filled: Manufacturing Technician (Support) provides support for Production Operations
6/14 filled: FAC 060613 Calibration/Maintenance Technician II
6/21 filled: MACC 2010 Manufacturing Associate - Cell Culture
7/16 added : QC 07162013 QC Analyst
7/18 added : M 07182013 Manufacturing Technician -
7/30 added : EMT 073013 Environmental Monitoring Technician
8/24 filled: QC 07162013 - QC Analyst Dept: Quality Control ... was removed sometime between 8/16 - 8/24
9/18 filled: M 07182013 - Manufacturing Technician
9/18 filled: EMT 073013 - Environmental Monitoring Technician
9/18 added: STM2012 Technician, Sr. Maintenance
10/14 added: EMT 073013 Sr. Environmental Monitoring Technician
10/20 filled:EMT 073013 Sr. Environmental Monitoring Technician
11/21 added: QCM 112113 Microbiologist
12/4 filled: STM2012 Technician, Sr. Maintenance Facilities & Maintenance
1/22 added: V 012214 Software Validation Engineer
--------------------------------------------------------------
Job Code V 012214
Job Type Full-time
Job Status Interviewing
Location Tustin, CA
Department Validation
Company Information Avid Bioservices, Inc.
14282 Franklin Ave
Tustin, CA 92780
Website: http://www.avidbio.com
Job Description SUMMARY
This position shall provide technical validation support for computer systems, networks, and software that have been newly installed, upgraded, replaced and/or modified in the cGMP Manufacturing Facility as well as its related manufacturing support areas, which may include Facilities/Engineering, Quality Assurance, Supply Chain, and Quality Control.
ESSENTIAL DUTIES AND RESPONSIBILITIES
• Author User Requirement Specification (URS) and/or Requirement Specification documents for equipment/systems/software and processes.
• Generate and execute Installation, Operational and Performance/Process qualification (IQ, OQ, PQ) protocols, engineering studies and final reports that comply with corporate and regulatory requirements.
• Coordinate and oversee validation protocol execution or validation activities with cross-functional departments.
• Evaluate and analyze qualification data collected during projects, while verifying acceptability of the data and compliance with the approved protocol.
• Ensure any deviations to protocols and/or deviations to acceptance criteria are adequately addressed, documented reviewed and approved prior to the final summary report approval.
• Provide input and assist on the development of validation policies and procedures.
• Effectively interact and provide validation guidance to other departments.
• Assist department manager in developing realistic time and resource requirements for validation activities in support of company expectation.
• Provide input and assist in change control assessment and Part 11 assessment for validated systems.
• Review Standard Operating Procedures (SOPs) and ensure the operational parameters described in the SOP for the equipment reflect the validated conditions.
• Assist department manager on other types of projects/managerial responsibilities as needed.
QUALIFICATIONS
• Knowledge of validation principles, standard concepts, practices, procedures and requirements in GMP regulated environment with special focus on computerized systems and software.
• Additional experience may include but not limited to knowledge and understanding of manufacturing processes and equipment/process gap analysis.
• Understanding of Good Automated Manufacturing Practice (GAMP), ASTM E2500, SDLC, Risk Assessment and 21 CFR Part 11 Electronic Records and Electronic Signatures.
• Knowledgeable with Programmable Logic Controllers (hardware and software).
• Normally receives general instructions on routine validation work and on new assignments/projects.
• Relies on experience and judgment to plan and accomplish goals.
• Multi-tasks, is organized and capable of working independently with minimal supervision.
• Looks for opportunities to assist others and works well in a team environment.
• Communicates effectively with customers, peers, and management.
• Demonstrates respect and appreciation for a diversity of perspectives.
• Maintains professionalism in presence of conflict.
• Takes accountability for actions, drives results, and learns from mistakes.
• Practical experience with quality risk management and risk-based validation.
• Demonstrates excellent organizational and time management skills.
EDUCATION AND/OR EXPERIENCE
• Requires a BA/BS in a Computer Science or other related technology field
• Minimum of 3 years of computer system/software validation experience or an equivalent combination of education and experience.
• Minimum of 3 years in the pharmaceutical or biopharmaceutical industry with GMP experience.
COMPUTER SKILLS
• Knowledge of Microsoft Word, Excel, Outlook, Access and Power Point.
• Knowledge of Microsoft SharePoint.
• Knowledge of Asset Management Systems
• Familiarity with Microsoft Project, Visio and other tracking/database software.
• Familiarity with SCADA systems (hardware and software).
• Familiarity with Building Automation Systems (BAS).
http://www.avidbio.com/about-us/careers.html?task=view&id=86
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!
Recent CDMO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:50:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:48:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 08:40:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 08:30:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:02:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:02:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:01:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:01:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:00:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:00:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/11/2024 12:23:26 AM
- Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024 • GlobeNewswire Inc. • 07/02/2024 08:05:04 PM
- Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024 • GlobeNewswire Inc. • 07/01/2024 11:00:21 AM
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM